Colorectal cancer
Conditions
Interventions
Experimental group:Gold bifidus and montmorillonite powder were added on the 1st, 2nd, 3rd and 4th days after surgery (gold bifidus (2g once three times a day), montmorillonite powder (once a bag thre
Control group:Conventional treatment
Sponsors
The First People's Hospital of Shuangliu District, Chengdu
Eligibility
Sex/Gender
All
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age 30 ~ 80 years old. (2) American Society of Anesthesiologists (ASA) Grade I to II. (3) Biopsy results confirmed colorectal malignancy. (4) There was no evidence of widespread metastasis. (5) Laparoscopic colorectal resection was performed with the patient's consent. (6) Obtain the consent of patients to conduct this study, and the compliance is good.
Exclusion criteria
Exclusion criteria: (1) There are contraindications of laparoscopic surgery (such as extensive intraperitoneal adhesion, etc.). (2) Emergency surgery. (3) There were obvious manifestations of intestinal obstruction or intestinal paralysis before surgery. (4) The tumor is not resectable. (5) Conversion to open surgery. (6) Reoperation within a short period (within 15d). (7) Persistent uncorrected water and electrolyte disturbances (such as hypokalemia, hypomagnesia, etc.). (8) Those who have used similar drugs such as Smecta and gold bifidus during the same period. (9) Unwilling to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum D-lactic acid ;hemoendotoxin;Plasma diamine oxidase (DAO) activity;tumor necrosis factor a;Interleukin-1;Postoperative recovery of gastrointestinal function; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of postoperative infectious complications;Postoperative recovery; | — |
Countries
China
Contacts
Public ContactYONG YANG
The First People's Hospital of Shuangliu District, Chengdu
Outcome results
None listed